Skip to main content
Caplight Logo









MedAngle

MedAngle

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://medangle.com

Last Round

Accelerator

Jan 18, 2022

Company Overview

MedAngle operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was an Accelerator round in January 2022.

MedAngle is an educational software company that provides an AI-powered digital platform and super app for medical, dental, and pre-medical students to navigate their studies.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Vertical SaaS, NLP & Conversational AI

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MedAngle Comparables

Compare MedAngle with similar companies based on industry and business-model similarity.

MedAngle comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMBOSS
81%
MedEd
80%
Geeky Medics
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MedAngle Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 18, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Mohammad Azib

Founder, CEO & CTO

Founding Team

For institutional investors. Book with your work email.

MedAngle Investors

Notable investors and investment history

MedAngle investors
InvestorRounds
Katalyst LabsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 18, 2022

    Received funding from Katalyst Labs.

Book a demo to see all signals

For institutional investors. Book with your work email.

MedAngle Filings

Explore SEC and related filing metadata, where available.

MedAngle filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MedAngle's valuation, stock price, and market status.

Is MedAngle a public or private company?

MedAngle is a private company.

What is the current stock price of MedAngle?

MedAngle is a private company, so its shares have no public market price. Caplight tracks MedAngle's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MedAngle worth (valuation)?

Valuation information for MedAngle is not publicly available.

Can I buy MedAngle stock?

MedAngle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MedAngle's last funding round?

MedAngle's most recent funding round was Accelerator on January 18, 2022.

Who are the main investors in MedAngle?

Key investors in MedAngle include Katalyst Labs.

Will MedAngle IPO soon?

No public IPO plans have been announced for MedAngle.

How can I track MedAngle secondary market activity?

Caplight tracks bids, offers, and trades in MedAngle's shares on secondary markets.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range302
Year Founded2017
Last FundingJan 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?